SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Interactive map of fiscal 2011 FDA cGMP warning letters

By Nick Taylor , 26-Apr-2012
Last updated on 26-Apr-2012 at 10:06 GMT

In-PharmaTechnologist presents an interactive map showing the global distribution of US FDA cGMP warning letters in fiscal 2011.

As reported earlier this week, the US Food and Drug Administration (FDA) continued to crackdown on overseas manufacturing plants last fiscal year with a 40 per cent increase in warning letters.

Sites in Mexico and India accounted for one-third of overseas production plants cited in FDA cGMP (current good manufacturing practice) warning letters last year. The map below shows the sites of these production plants and every other facility named by the FDA in fiscal 2011 warning letters.

North America and Western Europe account for many of the warning letters. For the first time since 2009 the FDA sent no warning letters to facilities in South America, leaving India and China as the emerging market hotbeds of regulatory enforcement actions.


View Warning Letters 2011 in a larger map

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events

 

Access all events listing

Our events, Events from partners...